Carolinas HealthCare System

Research and Clinical Trials

Title  
Progenics MIP-1404-3301
Brief Description  
Men with biopsy-proven low grade prostate cancer who are candidates for active surveillance, but have planned to undergo radical prostatetomy
Who may be Eligible  
Male > 18 years with serum PSA < 15.
Start Date  
03/01/2016
IRB Number  
09-16-04A
Principal Investigator  
Lipsitz, David
Contact Name  
Jennie

For More Information, Contact   Virginia  Bridges
Phone:  (704) 786-2931  Fax:  (704) 782-3640 
Email:  jbridges@carolinaclinicaltrials.com
Address:  1084 Vinehaven Drive
Concord, NC 28025
Close